GlassScriptPhysician profile
Sue B Onispir-Kafali
NPI 1255515201
$2,043.10
in general payments reported to CMS, 2019-2025
25 companies · $93.29 in 2025
The $93.29 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $174 · 2021: $198 · 2022: $447 · 2023: $451 · 2024: $246 · 2025: $93.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $494.74 | 2019-2024 | |
| Exeltis, USA INC. | $241.72 | 2021-2025 | Slynd |
| Coopersurgical, INC. | $206.34 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $177.56 | 2019-2025 | Aptima, Coolseal Generator, Fluent Fluid Management System |
| Intuitive Surgical, INC. | $168.17 | 2019 | |
| Mayne Pharma Commercial LLC | $166.66 | 2023-2025 | |
| Avion Pharmaceuticals | $71.80 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $56.59 | 2023 | Myfembree |
| Myovant Sciences INC. | $53.82 | 2022 | |
| Shield Therapeutics INC | $48.97 | 2022-2023 | Accrufer |
| Minerva Surgical, INC | $47.84 | 2022 | |
| Pfizer INC. | $46.25 | 2023 | |
| Meditrina | $38.00 | 2022 | |
| Agile Therapeutics, INC. | $24.97 | 2023 | Twirla |
| Ethicon US, LLC | $24.20 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23.81 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.47 | 2024 | |
| Channel Medsystems, INC. | $18.54 | 2022 | |
| Therapeuticsmd, INC. | $18.18 | 2020 | |
| Dysis Medical, INC. | $17.55 | 2019 | |
| Novo Nordisk INC | $16.19 | 2019 | |
| Coloplast Corp | $16.10 | 2021 | |
| Aspira Women'S Health INC | $15.77 | 2021 | |
| Boston Scientific Corporation | $15.56 | 2021 | |
| Galderma Laboratories, L.P. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sue Onispir-Kafali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.